Orchidee Double Defense Skin Shield
- Product NDC
- 72104-588
- 11-digit product format
- 721040588
- Labeler code
- 72104
- Product ID
- 72104-588_4b161c66-3080-4116-8c42-0da683fa11f7
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Octinoxate, Homosalate, Octisalate, Oxybenzone and Avobenzone
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Innovation Brands Inc.
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-27
- Substance
- OCTINOXATE; HOMOSALATE; OCTISALATE; OXYBENZONE; AVOBENZONE
- Active strength
- 7.4; 6.2; 5; 3.1; 1.5 g/100g; g/100g; g/100g; g/100g; g/100g
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 72104-588 | 72104-588-14 | D | Discontinued by firm | 2026-11-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 72104-588-14 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 72104-588-14 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 72104-588-14 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 72104-588-14 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 72104-588-14 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 72104-588-14 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 72104-588-14 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 72104-588-14 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 72104-588-14 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Orchidee Double Defense Skin Shield
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OCTINOXATE | 7.4 g/100g |
| HOMOSALATE | 6.2 g/100g |
| OCTISALATE | 5 g/100g |
| OXYBENZONE | 3.1 g/100g |
| AVOBENZONE | 1.5 g/100g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4Y5P7MUD51 | Internal UNII lookup |
| V06SV4M95S | Internal UNII lookup |
| 4X49Y0596W | Internal UNII lookup |
| 95OOS7VE0Y | Internal UNII lookup |
| G63QQF2NOX | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 74b3c33f-5db5-460d-97be-fa495b625249 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2025-07-01 | Orchidèe Double Defense Skin Shield Cream |
| 2025-01-30 | Orchidèe Double Defense Skin Shield Cream |
| 2022-08-09 | Orchidèe Double Defense Skin Shield Cream |
| 2022-07-29 | Orchidèe Double Defense Skin Shield Cream |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72104-588-14 | Orchidee Double Defense Skin Shield | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 72104-588-14 | Orchidee Double Defense Skin Shield | 50 g in 1 JAR | CREAM | 50 | 3 | |
| 72104-588-62 | Orchidee Double Defense Skin Shield | 1 in 1 CARTON | CREAM | 1 | 3 | |
| 72104-588-62 | Orchidee Double Defense Skin Shield | 62 g in 1 JAR | CREAM | 62 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72104-588 | ORCHIDEE DOUBLE DEFENSE SKIN SHIELD (OCTINOXATE, HOMOSALATE, OCTISALATE, OXYBENZONE AND AVOBENZONE) CREAM [LIONESSE USA, INC.] | 2 | Current NDC, Legacy NDC, 4 package rows | 20220811_74b3c33f-5db5-460d-97be-fa495b625249.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphe SPF 30 Broad Spectrum Sunsetter Setting | OCTISALATE, OCTOCRYLENE, AVOBENZONE, HOMOSALATE | COSMAX USA, CORPORATION | 0d34406f-9dd0-3909-e063-6394a90ab9f9 | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c64cc0-be42-c210-e063-6394a90a6d9a | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c61c42-edda-1ebd-e063-6294a90aee13 | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c62206-d839-8d9a-e063-6394a90a4c69 | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c62206-d83b-8d9a-e063-6394a90a4c69 | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c618ae-3d24-8c87-e063-6394a90a5396 | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c62206-d830-8d9a-e063-6394a90a4c69 | 2024-12-26 | Warnings | M020 |
| Bubble Solar Mate Daily Mineral Sunscreen SPF 40 | ZINC OXIDE | COSMAX USA, CORPORATION | 0d35fa3c-e6eb-d9ff-e063-6394a90a5a6e | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c6035e-c178-b3e6-e063-6394a90a86cd | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c62206-d838-8d9a-e063-6394a90a4c69 | 2024-12-26 | Warnings | M020 |
| Ulta Beauty Tinted Moisturizer Cream Spf 24 Light | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Cosmax Usa, Corporation | fbbff4eb-a63e-b083-e053-6294a90a404a | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c6035e-c179-b3e6-e063-6394a90a86cd | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c618ae-3d4d-8c87-e063-6394a90a5396 | 2024-12-26 | Warnings | M020 |
| KOPARI Sun Shield Soft Glow Daily Face SPF30 | OCTISALATE, OCTOCRYLENE, AVOBENZONE, HOMOSALATE | COSMAX USA, CORPORATION | 0d436d06-3f81-b4a6-e063-6294a90aa635 | 2024-12-26 | Warnings | M020 |
| NEORA Invisibloc Sunscreen Gel Broad Spectrum SPF40 | AVOBENZONE, HOMOSALATE, OCTISALATE | COSMAX USA, CORPORATION | 0d584736-3f55-2542-e063-6294a90af3cf | 2024-12-26 | Warnings | M020 |
| NARS Radiance Primer Broad Spectrum SPF 35 Sunscreen | OCTISALATE, OCTOCRYLENE, AVOBENZONE, HOMOSALATE | COSMAX USA, CORPORATION | 0d59d9cb-c891-1097-e063-6394a90a806e | 2024-12-26 | Warnings | M020 |
| KOPARI Sun Shield Soft Glow Daily Face SPF30 | OCTISALATE, OCTOCRYLENE, AVOBENZONE, HOMOSALATE | COSMAX USA, CORPORATION | 0d3673da-822b-09e2-e063-6394a90a348e | 2024-12-26 | Warnings | M020 |
| Buildable Blur | HOMOSALATE, OCTISALATE, ZINC OXIDE | COSMAX USA, CORPORATION | 06c61c42-eddb-1ebd-e063-6294a90aee13 | 2024-12-26 | Warnings | M020 |
| GLOSSIER INVISIBLE SHIELD DAILY SUNSCREEN BROAD SPECTRUM SPF 35 | AVOBENZONE, HOMOSALATE, OCTISALATE | COSMAX USA, CORPORATION | 0d438692-cd83-ea42-e063-6394a90a862d | 2024-12-26 | Warnings | M020 |
| KOPARI Antioxidant Face Shield Mineral SPF 30 | ZINC OXIDE | COSMAX USA, CORPORATION | 0d43e22c-5e3d-df90-e063-6294a90aac2b | 2024-12-26 | Warnings | M020 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72104-588-14 | 72104058814 | 1 JAR in 1 CARTON (72104-588-14) > 50 g in 1 JAR | 1 jar | 2021-08-27 | 0000-00-00 | No | No | Current |
| 72104-588-62 | 72104058862 | 1 JAR in 1 CARTON (72104-588-62) / 62 g in 1 JAR | 1 jar | 2021-08-27 | No | No | Current |